Our Worldwide Presence
Investing in product development and regulatory dossiers to support partners across South Asia, Southeast Asia, CIS/Central Asia, Africa, and LATAM.
Our Footprints & Target Export Markets
PEC Pharma has invested in product development with DMF and Dossiers regulatory support which helps to get easy penetration in the international market. This strategic investment means our partners can file registrations faster and with greater confidence in the quality documentation behind each product.
Our core export footprint spans 5 strategic global regions — South Asia (Bangladesh, Nepal, Sri Lanka), Southeast Asia (Vietnam, Cambodia, Myanmar, Philippines), CIS / Central Asia (Kazakhstan, Uzbekistan, Azerbaijan, Georgia), Africa (Kenya, Nigeria, Ghana, Tanzania, Morocco, Francophone West Africa), and LATAM (Bolivia, Peru, Guatemala, Dominican Republic, Venezuela).
With 50+ ready-to-file DMF and ACTD dossiers for APIs and formulations, PEC Pharma is positioned as a reliable supply partner for companies entering new geographic markets. We collaborate with manufacturers complying with regulatory support for both domestic and international requirements.
Expanding Further
PEC Pharma aims to enter into stringent regulatory markets in years to come, consistently ensuring compliance and excellence. Our technology-based approach and strong R&D setup support this ambition by enabling innovative production and niche market development.
International partners benefit from a single contact point for API supply, finished formulations, intermediates, impurity standards and CDMO services — simplifying procurement across multiple product categories for multi-country rollouts.
Our Worldwide Presence
50+ Ready-to-file
DMF & ACTD dossiers for API and formulations, supporting our partners in faster product registration.
Frequently Asked Questions
Which key target regions does PEC Pharma export APIs & Formulations to?
PEC Pharma actively exports commercial APIs, specialty intermediates, and finished formulations across 5 key target regions: South Asia (Bangladesh, Nepal, Sri Lanka), Southeast Asia (Vietnam, Cambodia, Myanmar, Philippines), CIS/Central Asia (Kazakhstan, Uzbekistan, Azerbaijan, Georgia), Africa (Kenya, Nigeria, Ghana, Tanzania, Morocco, Francophone West Africa), and LATAM (Bolivia, Peru, Guatemala, Dominican Republic, Venezuela).
How many dossiers does PEC Pharma have ready for filing?
We have 50+ ready-to-file DMF and ACTD dossiers for APIs and formulations, supporting our partners in faster product registration in international markets.
Which target countries does PEC Pharma supply in South Asia, SEA, CIS, Africa and LATAM?
Our primary target export countries include Bangladesh, Nepal, Sri Lanka, Vietnam, Cambodia, Myanmar, Philippines, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Kenya, Nigeria, Ghana, Tanzania, Morocco, Francophone West Africa, Bolivia, Peru, Guatemala, Dominican Republic, and Venezuela.
Does PEC Pharma plan to enter more stringent regulatory markets?
Yes. PEC Pharma aims to enter into stringent regulatory markets in years to come, consistently ensuring compliance and excellence.
How can international partners work with PEC Pharma?
Contact our team to discuss product availability, dossier documentation, regulatory support and supply terms for your target market. Visit our contact page or email info@pecpharma.in.